Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Marine biotin degerming liquid for treating onychomycosis and paronychia

A technology for marine bioactives and paronychia, which is applied in the field of marine bioactives sterilizing onychomycosis (onychomycosis) and paronychia treatment solution, can solve the problem of skin corrosion and irritation, no long-term antibacterial effect, Insufficient treatment effect and other problems, to achieve the effect of non-irritating skin, long-term antibacterial effect is significant and stable, and antibacterial effect is remarkable

Inactive Publication Date: 2012-07-11
QINGDAO HIFUN MARINE BIOLOGICAL TECH
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There are many kinds of medicines on the market to treat such diseases, and the general characteristics are: most of them are mainly treated with chemical medicines and traditional Chinese medicines, and most of them have poor treatment effects, complicated treatment courses, untimely treatment, long healing time, and pungent smell. , no long-term antibacterial effect, some chemical drugs have the disadvantages of corrosion and irritation to the skin

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

specific Embodiment approach

[0054] detailed description : below in conjunction with embodiment the present invention will be described in further detail:

[0055] Configure according to the data listed in the table below (% by weight) and the steps described:

[0056] Recipe one:

[0057] β-chitosan quaternized hyaluronic acid derivatives 1.0;

[0058] Seaweed polysaccharide derivatives 0.5-1.0;

[0059] Marine α-helical cecropin 6.0;

[0060] Cationic Polyguanidine 3.0;

[0061] Marine Bioactives 0.5-1.0;

[0062] Glycerin 2.0-3.0;

[0063] Seaweed agent 1.0-4.0;

[0064] deionized water to 100.

[0065]

[0066] Recipe 2:

[0067] β-chitosan quaternized hyaluronic acid derivatives 1.50;

[0068] Seaweed polysaccharide derivatives 0.5-1.0;

[0069] Marine α-helical cecropin 7.0;

[0070] Cationic polymeric guanidine 3.50;

[0071] Marine Bioactives 0.5-1.0;

[0072] Glycerin 2.0-3.0;

[0073] Seaweed agent 1.0-4.0;

[0074] deionized water to 100.

[0075] Recipe three:

[0076] ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to marine biotin degerming liquid for treating onychomycosis (leuconychia) and paronychia. The marine biotin degerming liquid is prepared by compounding beta-chitosan quaternize hyaluronic acid derivatives, alga polysaccharide derivatives, marine biological alpha-helical cecropin, marine biotin, cationic polymerization guanidine, glycerol and an alga agent. The marine biotin degerming liquid is mainly used for treating various types of onychomycosis (leuconychia) and paronychia, and can treat onychomycosis (leuconychia) and paronychia which are caused by various bacteria. Compared with the conventional treatment liquid, the marine biotin degerming liquid has the advantages of high sterilizing rate, no toxicity, no irritation, no corrosion, short cure time and the like. According to a formula, the marine biotin degerming liquid for treating the onychomycosis (leuconychia) and the paronychia comprises the following components in percentage by weight: 1.0 to 2.0 percent of beta-chitosan quaternize hyaluronic acid derivatives, 0.5 to 1.0 percent of alga polysaccharide derivatives, 6.0 to 8.0 percent of marine biological alpha-helical cecropin, 3.0 to 4.0 percent of cationic polymerization guanidine, 0.5 to 1.0 percent of marine biotin, 2.0 to 3.0 percent of glycerol, 1.0 to 4.0 percent of alga agent and 100 percent of deionized water.

Description

technical field [0001] The invention relates to a treatment solution for onychomycosis (onychomycosis) and paronychia treated with marine bioactive elements, the active ingredients of which are β-chitosan quaternized hyaluronic acid derivatives and seaweed polysaccharide derivatives. It is compounded by special process, including marine biological α-helical cecropin, marine biological activity, cationic polymerized guanidine, glycerin, and seaweed agent. It is mainly used to treat various types of onychomycosis (ononychomycosis) and paronychia. There are many kinds of medicines on the market to treat such diseases, and the general characteristics are: most of them are mainly treated with chemical medicines and traditional Chinese medicines, and most of them have poor treatment effects, complicated treatment courses, untimely treatment, long healing time, and pungent smell. , No long-term antibacterial effect, and some chemical drugs have the disadvantages of corrosion and irr...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/02A61P17/00A61P31/04A61P31/10A61K31/715A61K31/728A61K31/785A61K35/02
Inventor 李艳妮王鑫陈芬
Owner QINGDAO HIFUN MARINE BIOLOGICAL TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products